Epithelial to Mesenchymal Transition is Associated with Shorter Disease-Free Survival in Hepatocellular Carcinoma

[1]  Y. Hoshida,et al.  Genomic profiling of cell lines for personalized targeted therapy for hepatocellular carcinoma , 2013, Hepatology.

[2]  Kristen Jepsen,et al.  Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling , 2013, Cell.

[3]  V. Odero-Marah,et al.  The role of Snail in prostate cancer , 2012, Cell adhesion & migration.

[4]  Zhi-Hua Zhu,et al.  Twist expression associated with the epithelial-mesenchymal transition in gastric cancer , 2012, Molecular and Cellular Biochemistry.

[5]  Hui Zhao,et al.  Epithelial–Mesenchymal Transition Predicts Sensitivity to the Dual IGF-1R/IR Inhibitor OSI-906 in Hepatocellular Carcinoma Cell Lines , 2011, Molecular Cancer Therapeutics.

[6]  Ya-Shih Tseng,et al.  The correlation between TWIST, E-cadherin, and beta-catenin in human bladder cancer. , 2011, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[7]  S. Fan,et al.  The significance of early alpha-fetoprotein level changes in predicting clinical and survival benefits in advanced hepatocellular carcinoma patients receiving sorafenib. , 2011, The oncologist.

[8]  Chih-Hung Hsu,et al.  Early alpha‐fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma , 2010, Cancer.

[9]  Y. Muragaki,et al.  SNAIL induces epithelial-to-mesenchymal transition in a human pancreatic cancer cell line (BxPC3) and promotes distant metastasis and invasiveness in vivo. , 2010, Experimental and molecular pathology.

[10]  S. Natsugoe,et al.  Significance of Twist expression and its association with E-cadherin in esophageal squamous cell carcinoma , 2009, Journal of experimental & clinical cancer research : CR.

[11]  S. Chiou,et al.  Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma , 2009, Hepatology.

[12]  Derek Y. Chiang,et al.  Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. , 2009, Cancer research.

[13]  F. Vesuna,et al.  Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells , 2009, Oncogene.

[14]  Y. Nakanishi,et al.  Twist expression promotes migration and invasion in hepatocellular carcinoma , 2009, BMC Cancer.

[15]  Huamin Wang,et al.  Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. , 2009, Cancer research.

[16]  Vincent Wai-Sun Wong,et al.  High serum interleukin‐6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B , 2009, International journal of cancer.

[17]  Robert A. Weinberg,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[18]  T. Rosol,et al.  Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner. , 2008, Cancer Research.

[19]  Robert A. Weinberg,et al.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. , 2008, Developmental cell.

[20]  G. McCaughan,et al.  Hepatocellular carcinoma development requires hepatic stem cells with altered transforming growth factor and interleukin‐6 signaling , 2008, Hepatology.

[21]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[22]  T. Fujii,et al.  Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells. , 2008, Cancer research.

[23]  C. Porta,et al.  Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  D. Santini,et al.  IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. , 2007, The Journal of clinical investigation.

[25]  A. Axel,et al.  Interleukin‐6 is a potent growth factor for ER‐α‐positive human breast cancer , 2007 .

[26]  G. Z. Cheng,et al.  Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. , 2007, Cancer research.

[27]  S. Boyault,et al.  Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets , 2007, Hepatology.

[28]  Sheung Tat Fan,et al.  Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transition. , 2006, Cancer research.

[29]  Sheung Tat Fan,et al.  Twist Overexpression Correlates with Hepatocellular Carcinoma Metastasis through Induction of Epithelial-Mesenchymal Transition , 2006, Clinical Cancer Research.

[30]  A. Puisieux,et al.  A twist for survival and cancer progression , 2005, British Journal of Cancer.

[31]  G. Giannelli,et al.  Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma. , 2005, Gastroenterology.

[32]  S. Bapat,et al.  Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level. , 2005, Gynecologic oncology.

[33]  O. Lee,et al.  In vitro hepatic differentiation of human mesenchymal stem cells , 2004, Hepatology.

[34]  S. Ramaswamy,et al.  Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.

[35]  J. Thiery.  Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[36]  Francisco Portillo,et al.  The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression , 2000, Nature Cell Biology.

[37]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[38]  A. Axel,et al.  Interleukin-6 is a potent growth factor for ER-alpha-positive human breast cancer. , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  Michael Karin,et al.  References and Notes Supporting Online Material Materials and Methods Som Text Figs. S1 to S6 Tables S1 to S4 Gender Disparity in Liver Cancer Due to Sex Differences in Myd88-dependent Il-6 Production , 2022 .

[40]  H. M. A. Elmoneim,et al.  CLINICS 2011;66(10):1765-1771 DOI:10.1590/S1807-59322011001000015 CLINICAL SCIENCE Expression of e-cadherin, n-cadherin and snail and , 2022 .